Exact Mass: 385.0533668

Exact Mass Matches: 385.0533668

Found 101 metabolites which its exact mass value is equals to given mass value 385.0533668, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Cefaclor hydrate

Cefaclor Monohydrate

C15H16ClN3O5S (385.0499156)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic

   
   

4-oxo-6-((pyrimidin-2-ylthio)methyl)-4H-pyran-3-yl 4-nitrobenzoate

4-oxo-6-((pyrimidin-2-ylthio)methyl)-4H-pyran-3-yl 4-nitrobenzoate

C17H11N3O6S (385.0368546)


   

Zeanoside C

2-(3-hydroxy-2-oxo-7-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,3-dihydro-1H-indol-3-yl)acetic acid

C16H19NO10 (385.1008914)


Isolated from immature sweet corn kernels Zea mays (Gramineae). Zeanoside C is found in cereals and cereal products, fats and oils, and corn. Zeanoside A is found in cereals and cereal products. Zeanoside A is isolated from sweet corn kernels Zea mays (Gramineae).

   

(S)-2,3-Dihydro-3,5-dihydroxy-2-oxo-3-indoleacetic acid 5-glucoside

2-(3-hydroxy-2-oxo-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,3-dihydro-1H-indol-3-yl)acetic acid

C16H19NO10 (385.1008914)


(S)-2,3-Dihydro-3,5-dihydroxy-2-oxo-3-indoleacetic acid 5-glucoside is found in cereals and cereal products. (S)-2,3-Dihydro-3,5-dihydroxy-2-oxo-3-indoleacetic acid 5-glucoside is a constituent of rice bran Constituent of rice bran. (R)-2,3-Dihydro-3,5-dihydroxy-2-oxo-3-indoleacetic acid 5-glucoside is found in cereals and cereal products.

   

(-)-Epigallocatechin sulfate

(2S,3S)-8-Hydroxy-3-(sulphooxy)-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-6-olic acid

C15H13O10S- (385.0229418)


Epigallocatechin sulfate is the sulfated form of epigallocatechin, wherein the sulfate group is attached to the O-3 position. Sulfation is a phase II biotransformation reaction that involves a sulfotransferase enzyme catalyzing the transfer of a sulfo group from a donor cosubstrate, usually 3-phosphoadenosine-5-phosphosulfate (PAPS), to a substrate molecules hydroxyl group (in this case epigallogatechin). Sulfation is involved in a variety of biological processes, including detoxification, hormone regulation, molecular recognition, cell signaling, and viral entry into cells. Epigallocatechin (EGC) is a flavan-3-ol, which are derivatives of flavans that possess a 2-phenyl-3,4-dihydro-2H-chromen-3-ol skeleton. EGC is one of the antioxidant chemicals found in many fruits and teas. This compound possesses an epimer, found notably in green tea, called "gallocatechin" (GC) (PMID: 30917581), with the gallate residue being in an isomeric trans position. Other sources of gallocatechin are bananas, persimmon, and pomegranate. This compound had been shown to have moderate affinity to the human cannabinoid receptor, which may contribute to the health benefits found by consuming green tea.

   

Hydroxylansoprazole

2-{[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methanesulphinyl}-1H-1,3-benzodiazol-6-ol

C16H14F3N3O3S (385.0707930000001)


Hydroxylansoprazole is only found in individuals that have used or taken Lansoprazole. Hydroxylansoprazole is a metabolite of Lansoprazole. Hydroxylansoprazole belongs to the family of Sulfinylbenzimidazoles. These are polycyclic aromatic compounds containing a sulfinyl group attached at the position 2 of a benzimidazole moiety.

   

Lansoprazole sulfone

2-{[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methanesulphonyl}-1H-1,3-benzodiazole

C16H14F3N3O3S (385.0707930000001)


Lansoprazole sulfone is only found in individuals that have used or taken Lansoprazole. Lansoprazole sulfone is a metabolite of Lansoprazole. Lansoprazole sulfone belongs to the family of Sulfinylbenzimidazoles. These are polycyclic aromatic compounds containing a sulfinyl group attached at the position 2 of a benzimidazole moiety.

   

Alizarin complexone

2-[(carboxymethyl)[(3,4-dihydroxy-9,10-dioxo-9,10-dihydroanthracen-2-yl)methyl]amino]acetic acid

C19H15NO8 (385.079763)


   

beta-CIT

3-(4-Iodophenyl)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid methyl ester

C16H20INO2 (385.053873)


   

Mavacoxib

4-[5-(4-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzene-1-sulfonamide

C16H11F4N3O2S (385.05080740000005)


   

Aristolochic acid IVa methyl ester

Aristolochic acid IVa methyl ester

C19H15NO8 (385.079763)


   

3-[4-Methoxy-2-(trifluoromethyl)-6-quinolyl]prop-2-ynyl benzoate

3-[4-Methoxy-2-(trifluoromethyl)-6-quinolyl]prop-2-ynyl benzoate

C21H14F3NO3 (385.092573)


   
   

(1R+,5S+,6S*)-6,1h-Dichlor-5-hydroxy-9,3(1h)-axinyssadien-15-yl-carbonimid-dichlorid|axinyssane

(1R+,5S+,6S*)-6,1h-Dichlor-5-hydroxy-9,3(1h)-axinyssadien-15-yl-carbonimid-dichlorid|axinyssane

C16H23Cl4NO (385.0533668)


   
   

Aristolochic acid IV methyl ester

Aristolochic acid IV methyl ester

C19H15NO8 (385.079763)


   

anisodamine

BENZENEACETIC ACID, .ALPHA.-(HYDROXYMETHYL)-, 6-HYDROXY-8-METHYL-8-AZABICYCLO(3.2.1)OCT-3-YL ESTER, HYDROBROMIDE, (1R-(1.ALPHA.,3.BETA.(S*),5.ALPHA.,6.ALPHA.))-

C17H24BrNO4 (385.08886040000004)


Anisodamine hydrobromide (6-Hydroxyhyoscyamine hydrobromide), a belladonna alkaloid, is a non-subtype-selective muscarinic and a nicotinic cholinoceptor antagonist. Anisodamine hydrobromide shows antioxidant, anti-inflammatory properties[1][2]. Anisodamine hydrobromide (6-Hydroxyhyoscyamine hydrobromide), a belladonna alkaloid, is a non-subtype-selective muscarinic and a nicotinic cholinoceptor antagonist. Anisodamine hydrobromide shows antioxidant, anti-inflammatory properties[1][2].

   

Azasetron HCl

Azasetron HCl

C17H21Cl2N3O3 (385.09598960000005)


Azasetron (Y-25130) hydrochloride, a benzamide derivative, is a potent and selective 5-HT3 receptor antagonist. Azasetron is used in the study for Chemotherapy-induced nausea and vomiting (CINV)[1].

   
   

(S)-2,3-Dihydro-3,5-dihydroxy-2-oxo-3-indoleacetic acid 5-glucoside

2-(3-hydroxy-2-oxo-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,3-dihydro-1H-indol-3-yl)acetic acid

C16H19NO10 (385.1008914)


   
   

Zeanoside C

2-(3-hydroxy-2-oxo-7-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,3-dihydro-1H-indol-3-yl)acetic acid

C16H19NO10 (385.1008914)


   

OXODIPEROXY(PYRIDINE)(1,3-DIMETHYL-3,4,5,6-TETRAHYDRO-2(1H)-PYRIMIDINONE)MOLYBDENUM (IV)

OXODIPEROXY(PYRIDINE)(1,3-DIMETHYL-3,4,5,6-TETRAHYDRO-2(1H)-PYRIMIDINONE)MOLYBDENUM (IV)

C11H17MoN3O6 (385.01713520000004)


   

2,2,3-tris(4-chlorophenyl)propiononitrile

2,2,3-tris(4-chlorophenyl)propiononitrile

C21H14Cl3N (385.01917740000005)


   

6-BROMO-2-(3-ISOPROPOXYPHENYL)QUINOLINE-4-CARBOXYLICACID

6-BROMO-2-(3-ISOPROPOXYPHENYL)QUINOLINE-4-CARBOXYLICACID

C19H16BrNO3 (385.0313486)


   

Thiazolidine, 2-(4-methoxyphenyl)-3-(1-naphthalenylsulfonyl)- (9CI)

Thiazolidine, 2-(4-methoxyphenyl)-3-(1-naphthalenylsulfonyl)- (9CI)

C20H19NO3S2 (385.0806304000001)


   
   

6-BROMO-2-(2-ISOPROPOXYPHENYL)QUINOLINE-4-CARBOXYLICACID

6-BROMO-2-(2-ISOPROPOXYPHENYL)QUINOLINE-4-CARBOXYLICACID

C19H16BrNO3 (385.0313486)


   

6-BROMO-2-(4-ISOPROPOXYPHENYL)QUINOLINE-4-CARBOXYLICACID

6-BROMO-2-(4-ISOPROPOXYPHENYL)QUINOLINE-4-CARBOXYLICACID

C19H16BrNO3 (385.0313486)


   

2,3-dimethylnaphtho[1,2-d]thiazolium tosylate

2,3-dimethylnaphtho[1,2-d]thiazolium tosylate

C20H19NO3S2 (385.0806304000001)


   

tert-butyl 4-(4-bromo-2-methoxyphenoxy)piperidine-1-carboxylate

tert-butyl 4-(4-bromo-2-methoxyphenoxy)piperidine-1-carboxylate

C17H24BrNO4 (385.08886040000004)


   

Bis(ethylenediamine)platinum(II) chloride

Bis(ethylenediamine)platinum(II) chloride

C4H16Cl2N4Pt (385.03998060000004)


   

ethyl 2-piperazine-4-(3,5-dichloro)phenyl thiazole-5-carboxylate

ethyl 2-piperazine-4-(3,5-dichloro)phenyl thiazole-5-carboxylate

C16H17Cl2N3O2S (385.04184820000006)


   

(2-AMINO-2-METHYL-PROPYL)-UREA

(2-AMINO-2-METHYL-PROPYL)-UREA

C18H18Cl3NO2 (385.0403058)


   
   

METHYL 2-(2,4-DICHLORO-5-FLUOROBENZOYL)-3-((4-FLUOROPHENYL)AMINO)ACRYLATE

METHYL 2-(2,4-DICHLORO-5-FLUOROBENZOYL)-3-((4-FLUOROPHENYL)AMINO)ACRYLATE

C17H11Cl2F2NO3 (385.00840200000005)


   

[7-(2-nitrooxyethoxy)-4-oxo-2-phenylchromen-5-yl] acetate

[7-(2-nitrooxyethoxy)-4-oxo-2-phenylchromen-5-yl] acetate

C19H15NO8 (385.079763)


   

tert-butyl N-[4-(bromomethyl)phenyl]-N-[(2-methylpropan-2-yl)oxycarbonyl]carbamate

tert-butyl N-[4-(bromomethyl)phenyl]-N-[(2-methylpropan-2-yl)oxycarbonyl]carbamate

C17H24BrNO4 (385.08886040000004)


   

2-(4-Bromophenyl)-4,6-diphenylpyridine

2-(4-Bromophenyl)-4,6-diphenylpyridine

C23H16BrN (385.0466036)


   

3-AMINO-5-HYDROXY-PENTEN-1

3-AMINO-5-HYDROXY-PENTEN-1

C18H18Cl3NO2 (385.0403058)


   
   

YS-49

YS-49

C20H20BrNO2 (385.06773200000003)


YS-49 is a PI3K/Akt (a downstream target of RhoA) activator, to reduce RhoA/PTEN activation in the 3-methylcholanthrene-treated cells. YS-49 inhibits angiotensin II (Ang II)-stimulated proliferation of VSMCs via induction of heme oxygenase (HO)-1. YS-49 is also an isoquinoline compound alkaloid, has a strong positive inotropic action through activation of cardiac β-adrenoceptors[1][2][3]. YS-49 is a PI3K/Akt (a downstream target of RhoA) activator, to reduce RhoA/PTEN activation in the 3-methylcholanthrene-treated cells. YS-49 inhibits angiotensin II (Ang II)-stimulated proliferation of VSMCs via induction of heme oxygenase (HO)-1. YS-49 is also an isoquinoline compound alkaloid, has a strong positive inotropic action through activation of cardiac β-adrenoceptors[1][2][3].

   

N-{3-Chloro-4-[(2-chlorobenzoyl)amino]phenyl}-2-pyridinecarboxami de

N-[3-chloro-4-[[(2-chlorophenyl)-oxomethyl]amino]phenyl]-2-pyridinecarboxamide

C19H13Cl2N3O2 (385.0384778)


   

2-[4-[2-(trifluoromethyl)benzoyl]piperazin-1-yl]-1,3-thiazole-5-carboxylic acid

2-[4-[2-(trifluoromethyl)benzoyl]piperazin-1-yl]-1,3-thiazole-5-carboxylic acid

C16H14F3N3O3S (385.0707930000001)


   

Platinum(2+) hydrogen carbonate ammoniate (1:2:4)

Platinum(2+) hydrogen carbonate ammoniate (1:2:4)

C2H14N4O6Pt (385.0561154)


   

Arsonic acid,[4-[[4-(dimethylamino)phenyl]azo]phenyl]-, monohydrochloride (9CI)

Arsonic acid,[4-[[4-(dimethylamino)phenyl]azo]phenyl]-, monohydrochloride (9CI)

C14H17AsClN3O3 (385.0174342)


   

(3aR,4S,6R,6aS)-6-[7-Chloro-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]tetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-ol

(3aR,4S,6R,6aS)-6-[7-Chloro-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]tetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-ol

C15H20ClN5O3S (385.097532)


   

(Z)-methyl 1-(2-chloroacetyl)-3-(methoxy(phenyl)methylene)-2-oxoindoline-6-carboxylate

(Z)-methyl 1-(2-chloroacetyl)-3-(methoxy(phenyl)methylene)-2-oxoindoline-6-carboxylate

C20H16ClNO5 (385.07169560000006)


   
   

Azasetron

D-erythro-Sphingosine (Brain, Porcine)

C17H20ClN3O3·HCl (385.09598960000005)


C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist > C94726 - 5-HT3 Receptor Antagonist D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents Azasetron (Y-25130) hydrochloride, a benzamide derivative, is a potent and selective 5-HT3 receptor antagonist. Azasetron is used in the study for Chemotherapy-induced nausea and vomiting (CINV)[1].

   
   
   
   

ethyl 8-cyano-2-((4-fluorophenylthio)Methyl)-7-MethoxyiMidazo[1,2-a]pyridine-3-carboxylate

ethyl 8-cyano-2-((4-fluorophenylthio)Methyl)-7-MethoxyiMidazo[1,2-a]pyridine-3-carboxylate

C19H16FN3O3S (385.0896358)


   

(5-bromo-4-chloro-1H-indol-3-yl) nonanoate

(5-bromo-4-chloro-1H-indol-3-yl) nonanoate

C17H21BrClNO2 (385.04440960000005)


   

4-(4-Bromo-1H-pyrazol-1-yl)-N,N-diisopropylbenzenesulfonamide

4-(4-Bromo-1H-pyrazol-1-yl)-N,N-diisopropylbenzenesulfonamide

C15H20BrN3O2S (385.04595200000006)


   

tert-butyl 4-(4-bromo-2-fluorobenzoyl)piperidine-1-carboxylate

tert-butyl 4-(4-bromo-2-fluorobenzoyl)piperidine-1-carboxylate

C17H21BrFNO3 (385.0688748)


   

copper(ii) benzoylacetonate

copper(ii) benzoylacetonate

C20H18CuO4 (385.0501018)


   

Mavacoxib

Mavacoxib

C16H11F4N3O2S (385.05080740000005)


C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic C471 - Enzyme Inhibitor > C1323 - Cyclooxygenase Inhibitor

   

(3-Chlorophenyl)-[4-(7-chloro-4-quinolinyl)-1-piperazinyl]methanone

(3-Chlorophenyl)-[4-(7-chloro-4-quinolinyl)-1-piperazinyl]methanone

C20H17Cl2N3O (385.0748612)


   

5-[1-(4-Fluorophenyl)sulfonyl-3-pyrazolyl]-2-phenylthiazole

5-[1-(4-Fluorophenyl)sulfonyl-3-pyrazolyl]-2-phenylthiazole

C18H12FN3O2S2 (385.0354944)


   

(4-Chlorophenyl)-[4-(7-chloro-4-quinolinyl)-1-piperazinyl]methanone

(4-Chlorophenyl)-[4-(7-chloro-4-quinolinyl)-1-piperazinyl]methanone

C20H17Cl2N3O (385.0748612)


   
   

ethyl 1-[4-(2-fluorophenyl)-1,3-thiazol-2-yl]-5-(trifluoromethyl)-1H-pyrazole-4-carboxylate

ethyl 1-[4-(2-fluorophenyl)-1,3-thiazol-2-yl]-5-(trifluoromethyl)-1H-pyrazole-4-carboxylate

C16H11F4N3O2S (385.05080740000005)


   

Ethyl 5-[(2-chlorophenyl)sulfanyl]-3-(4-methylphenyl)-1,2,4-triazine-6-carboxylate

Ethyl 5-[(2-chlorophenyl)sulfanyl]-3-(4-methylphenyl)-1,2,4-triazine-6-carboxylate

C19H16ClN3O2S (385.06517060000004)


   

2-[[oxo-(1-oxo-3,4-dihydro-1H-2-benzopyran-3-yl)methyl]amino]-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylic acid methyl ester

2-[[oxo-(1-oxo-3,4-dihydro-1H-2-benzopyran-3-yl)methyl]amino]-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylic acid methyl ester

C20H19NO5S (385.0983884000001)


   

2-[(4-fluorophenyl)sulfonyl-(2-pyridinyl)amino]-N-phenylacetamide

2-[(4-fluorophenyl)sulfonyl-(2-pyridinyl)amino]-N-phenylacetamide

C19H16FN3O3S (385.0896358)


   

2-chloro-4-fluoro-N-[4-methoxy-3-(4-methoxyphenyl)phenyl]benzamide

2-chloro-4-fluoro-N-[4-methoxy-3-(4-methoxyphenyl)phenyl]benzamide

C21H17ClFNO3 (385.08809340000005)


   
   

[(2R,3S,4R,5S)-5-{2-amino-5-cyano-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-7-yl}-3,4-dihydroxyoxolan-2-yl]methyl phosphate

[(2R,3S,4R,5S)-5-{2-amino-5-cyano-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-7-yl}-3,4-dihydroxyoxolan-2-yl]methyl phosphate

C12H12N5O8P-2 (385.0423482)


   

(2S,4E)-4-[2-[(1S)-1-carboxylato-2-(3,4-dioxocyclohexa-1,5-dien-1-yl)ethyl]iminoethylidene]-2,3-dihydro-1H-pyridine-2,6-dicarboxylate

(2S,4E)-4-[2-[(1S)-1-carboxylato-2-(3,4-dioxocyclohexa-1,5-dien-1-yl)ethyl]iminoethylidene]-2,3-dihydro-1H-pyridine-2,6-dicarboxylate

C18H13N2O8-3 (385.0671878)


   

(4aR)-1,4a,8,10,11-pentahydroxy-3,12-dioxo-5,12a-dihydro-4H-tetracene-2-carboxamide

(4aR)-1,4a,8,10,11-pentahydroxy-3,12-dioxo-5,12a-dihydro-4H-tetracene-2-carboxamide

C19H15NO8 (385.079763)


   

N-[4-oxo-5-(2-oxo-1H-indol-3-ylidene)-2-thiazolyl]benzenesulfonamide

N-[4-oxo-5-(2-oxo-1H-indol-3-ylidene)-2-thiazolyl]benzenesulfonamide

C17H11N3O4S2 (385.0190966)


   

(1R,3S)-3-(4-iodophenyl)-8-methyl-8-azabicyclo[3.2.1]octane-4-carboxylic acid methyl ester

(1R,3S)-3-(4-iodophenyl)-8-methyl-8-azabicyclo[3.2.1]octane-4-carboxylic acid methyl ester

C16H20INO2 (385.053873)


   
   

(5E)-5-{[5-(1H-benzimidazol-2-ylthio)-2-furyl]methylene}-3-isopropyl-1,3-thiazolidine-2,4-dione

(5E)-5-{[5-(1H-benzimidazol-2-ylthio)-2-furyl]methylene}-3-isopropyl-1,3-thiazolidine-2,4-dione

C18H15N3O3S2 (385.05548000000005)


   

2,5-dimethoxy-N-(4-phenoxyphenyl)benzenesulfonamide

2,5-dimethoxy-N-(4-phenoxyphenyl)benzenesulfonamide

C20H19NO5S (385.0983884000001)


   

Versicolorone(1-)

Versicolorone(1-)

C20H17O8- (385.0923382)


An organic anion that is the conjugate base of versicolorone, obtained by selective deprotonation of the 2-hydroxy group.

   

(2S)-versicolorone(1-)

(2S)-versicolorone(1-)

C20H17O8- (385.0923382)


An organic anion obtained by selective deprotonation of the 2-hydroxy group of (2S)-versicolorone.

   

3-chloro-N-[3-nitro-5-(2-pyridinylthio)phenyl]benzamide

3-chloro-N-[3-nitro-5-(2-pyridinylthio)phenyl]benzamide

C18H12ClN3O3S (385.0287872)


   

4-chloro-3-(1-piperidinylsulfonyl)-N-(2-thiazolyl)benzamide

4-chloro-3-(1-piperidinylsulfonyl)-N-(2-thiazolyl)benzamide

C15H16ClN3O3S2 (385.03215759999995)


   

(S)-5-oxoaverantin(1-)

(S)-5-oxoaverantin(1-)

C20H17O8- (385.0923382)


A phenolate anion obtained by deprotonation of the 2-hydroxy group of (S)-5-oxoaverantin. It is the major microspecies at pH 7.3 (according to Marvin v 6.2.0.).

   

N-(4-bromo-5-methyl-2-oxo-3-indolyl)-3-phenylpropanehydrazide

N-(4-bromo-5-methyl-2-oxo-3-indolyl)-3-phenylpropanehydrazide

C18H16BrN3O2 (385.0425816)


   

N-[4-bromo-3-(trifluoromethyl)phenyl]-2,4,6-trimethylbenzamide

N-[4-bromo-3-(trifluoromethyl)phenyl]-2,4,6-trimethylbenzamide

C17H15BrF3NO (385.02890360000004)


   

4-(3-hydroxyphenyl)-1-(thiophen-2-ylmethyl)-4H-pyridine-3,5-dicarboxylic acid dimethyl ester

4-(3-hydroxyphenyl)-1-(thiophen-2-ylmethyl)-4H-pyridine-3,5-dicarboxylic acid dimethyl ester

C20H19NO5S (385.0983884000001)


   

1-[1-[(2-Chloro-6-fluorophenyl)methyl]-2-oxo-3-pyridinyl]-3-(phenylmethyl)urea

1-[1-[(2-Chloro-6-fluorophenyl)methyl]-2-oxo-3-pyridinyl]-3-(phenylmethyl)urea

C20H17ClFN3O2 (385.0993264)


   

1-(4-oxo-2-thieno[3,2-d][1,3]thiazinyl)-N-(phenylmethyl)-3-piperidinecarboxamide

1-(4-oxo-2-thieno[3,2-d][1,3]thiazinyl)-N-(phenylmethyl)-3-piperidinecarboxamide

C19H19N3O2S2 (385.09186339999997)


   

3-(4-chlorophenyl)-1-methyl-N-[(5-methyl-2-furanyl)methyl]-5-thieno[2,3-c]pyrazolecarboxamide

3-(4-chlorophenyl)-1-methyl-N-[(5-methyl-2-furanyl)methyl]-5-thieno[2,3-c]pyrazolecarboxamide

C19H16ClN3O2S (385.06517060000004)


   

[4-[(Z)-2-cyano-2-(6-methyl-1H-benzimidazol-2-yl)ethenyl]phenyl] thiophene-2-carboxylate

[4-[(Z)-2-cyano-2-(6-methyl-1H-benzimidazol-2-yl)ethenyl]phenyl] thiophene-2-carboxylate

C22H15N3O2S (385.088493)


   

N-[(2-chlorophenyl)-oxomethyl]-1-ethyl-4-hydroxy-2-oxo-3-quinolinecarbohydrazide

N-[(2-chlorophenyl)-oxomethyl]-1-ethyl-4-hydroxy-2-oxo-3-quinolinecarbohydrazide

C19H16ClN3O4 (385.08292860000006)


   

[5-(2-amino-5-carbamimidoyl-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-7-yl)-3-hydroxy-2,5-dihydrofuran-2-yl]methyl hydrogen phosphate

[5-(2-amino-5-carbamimidoyl-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-7-yl)-3-hydroxy-2,5-dihydrofuran-2-yl]methyl hydrogen phosphate

C12H14N6O7P- (385.0661564)


   

[5-[2-amino-5-(methylaminomethyl)-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-7-yl]-3-hydroxy-2,5-dihydrofuran-2-yl]methyl phosphate

[5-[2-amino-5-(methylaminomethyl)-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-7-yl]-3-hydroxy-2,5-dihydrofuran-2-yl]methyl phosphate

C13H16N5O7P-2 (385.0787316)


   

alizarin complexone

Alizarin fluorine blue

C19H15NO8 (385.079763)


   

Cytidine 5'-phosphate 2',3'-cyclic phosphate

Cytidine 5'-phosphate 2',3'-cyclic phosphate

C9H13N3O10P2 (385.0076178)


   

GLUT4-IN-2

GLUT4-IN-2

C17H11N3O4S2 (385.0190966)


GLUT4-IN-2 is a potent and selective GLUT4 inhibitor with IC50s of 11.4 μM and 6.8 μM for GLUT1 and GLUT4, respectively. GLUT4-IN-2 induces cell apoptosis and cell cycle arrest at G0/G1phase. GLUT4-IN-2 shows potent antitumor activity[1].